Noninvasive magnetic resonance imaging evaluation of endothelial permeability in murine atherosclerosis using an albumin-binding contrast agent

Circulation

Volumn 126, Issue 6, 2012, Pages 707-719

  Phinikaridou, Alkystis ^a   Andia, Marcelo E ^a,f   Protti, Andrea ^a,b   Indermuehle, Andreas ^a   Shah, Ajay ^b   Smith, Alberto ^b,c   Warley, Alice ^d   Botnar, René M ^a,b,e  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b Cardiovascular Division   (United States)

^c Academic Department of Surgery   (United States)

^d Center for Ultrastructural Imaging   (United States)

^e KING'S COLLEGE LONDON   (United Kingdom)

^f PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE   (Chile)

Author keywords

atherosclerosis; endothelial dysfunction; gadofosveset; magnetic resonance imaging; permeability

Indexed keywords

ACETYLCHOLINE; ALBUMIN; APOLIPOPROTEIN E; CONTRAST MEDIUM; EVANS BLUE; GADOFOSVESET; GALBUMIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; PRAVASTATIN; UNCLASSIFIED DRUG; VIPER VENOM;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATHEROSCLEROSIS; BLOOD VESSEL PERMEABILITY; BRACHIOCEPHALIC TRUNK; CARDIOVASCULAR MAGNETIC RESONANCE; CAROTID ARTERY; CONTRAST ENHANCEMENT; DRUG PROTEIN BINDING; ELECTROCARDIOGRAM; ENDOTHELIAL DYSFUNCTION; HISTOLOGY; IMMUNOHISTOCHEMISTRY; LIPID DIET; MALE; MASS SPECTROMETRY; MOUSE; NON INVASIVE PROCEDURE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SCANNER; PRIORITY JOURNAL; TRANSMISSION ELECTRON MICROSCOPY; VASCULAR ENDOTHELIUM; VASOCONSTRICTION; WESTERN BLOTTING; WILD TYPE; X RAY MICROANALYSIS;

ANIMALS; ATHEROSCLEROSIS; CAPILLARY PERMEABILITY; CONTRAST MEDIA; DRUG EVALUATION, PRECLINICAL; ENDOTHELIUM, VASCULAR; GADOLINIUM; MAGNETIC RESONANCE IMAGING; MALE; MICE; MICE, 129 STRAIN; MICE, INBRED C57BL; MICE, KNOCKOUT; MICE, TRANSGENIC; ORGANOMETALLIC COMPOUNDS; PROTEIN BINDING; SERUM ALBUMIN;

EID: 84864703182     PISSN: 00097322     EISSN: 15244539     Source Type: Journal    
DOI: 10.1161/CIRCULATIONAHA.112.092098     Document Type: Article

References (50)

1. Davignon J, Ganz P. Role of endothelial dysfunction in atherosclerosis. Circulation. 2004;109:III27-III32. (Pubitemid 38786440)
2. Cereijido M, Anderson JE. Tight Junctions. 2nd ed. Boca Raton, FL: CRC; 2001.
3. Zimmerman M, McGeachie J. Quantitation of the relationship between aortic endothelial intercellular cleft morphology and permeability to albumin. Atherosclerosis. 1986;59:277-282. (Pubitemid 16163843)
4. Gerrity R. Endothelial cell morphology in areas of in vivo Evans blue uptake in the aorta of young pigs. Am J Pathol. 1977;89:1-22.
5. Kao CH, Chen JK, Kuo JS, Yang VC. Visualization of the transport pathways of low density lipoproteins across the endothelial cells in the branched regions of rat arteries. Atherosclerosis. 1995;116:27-41.
6. Huynh J, Nishimura N, Rana K, Peloquin JM, Califano JP, Montague CR, King MR, Schaffer CB, Reinhart-King CA. Age-related intimal stiffening enhances endothelial permeability and leukocyte transmigration. Sci Transl Med. 2011;3:112-122.
7. Lee WC, Chao WT, Yang VC. Effects of high-cholesterol diet on the interendothelial clefts and the associated junctional complexes in rat aorta. Atherosclerosis. 2001;155:307-312. (Pubitemid 32209300)
8. Stefanovish V. Cholesterol diet and permeability of rabbit aorta. Exp Mol Pathol. 1971;14:20-29.
9. Gerrity RG, Naito HK, Richardson M, Schwartz CJ. Dietary induced atherogenesis in swine: morphology of the intima in prelesion stages. Am J Pathol. 1979;95:775-792. (Pubitemid 9182867)
10. Burrig KF. The endothelium of advanced arteriosclerotic plaques in humans. Arterioscler Thromb. 1991;11:1678-1689.
11. Ludmer PL, Selwyn AP, Shook TL, Wayne RR, Mudge GH, Alexander RW, Ganz P. Paradoxical vasoconstriction induced by acetylcholine in atherosclerotic coronary arteries. N Engl J Med. 1986;315:1046-1051. (Pubitemid 17170620)
12. Crauwels HM, Van Hove CE, Holvoet P, Herman AG, Bult H. Plaqueassociated endothelial dysfunction in apolipoprotein E-deficient mice on a regular diet: effect of human apolipoprotein AI. Cardiovasc Res. 2003; 59:189-199. (Pubitemid 36776385)
13. Bonthu S, Heistad DD, Chappell DA, Lamping KG, Faraci FM. Atherosclerosis, vascular remodeling, and impairment of endothelium-dependent relaxation in genetically altered hyperlipidemic mice. Arterioscler Thromb Vasc Biol. 1997;17:2333-2340. (Pubitemid 28015965)
14. Werns SW, Walton JA, Hsia HH, Nabel EG, Sanz ML, Pitt B. Evidence of endothelial dysfunction in angiographically normal coronary arteries of patients with coronary artery disease. Circulation. 1989;79:287-291. (Pubitemid 19055498)
15. Cai JM, Hatsukami TS, Ferguson MS, Small R, Polissar NL, Yuan C. Classification of human carotid atherosclerotic lesions with in vivo multicontrast magnetic resonance imaging. Circulation. 2002;106: 1368-1373. (Pubitemid 35013040)
16. Botnar RM, Stuber M, Kissinger KV, Kim WY, Spuentrup E, Manning WJ. Noninvasive coronary vessel wall and plaque imaging with magnetic resonance imaging. Circulation. 2000;102:2582-2587.
17. Wasserman BA, Smith WI, Trout HH III, Cannon RO III, Balaban RS, Arai AE. Carotid artery atherosclerosis: in vivo morphologic characterization with gadolinium-enhanced double-oblique MR imaging initial results. Radiology. 2002;223:566-573. (Pubitemid 34454344)
18. Yuan C, Kerwin WS, Ferguson MS, Polissar N, Zhang S, Cai J, Hatsukami TS. Contrast-enhanced high resolution MRI for atherosclerotic carotid artery tissue characterization. J Magn Reson Imaging. 2002;15: 62-67. (Pubitemid 34008147)
19. Maintz D, Ozgun M, Hoffmeier A, Fischbach R, Kim WY, Stuber M, Manning WJ, Heindel W, Botnar RM. Selective coronary artery plaque visualization and differentiation by contrast-enhanced inversion prepared MRI. Eur Heart J. 2006;27:1732-1736. (Pubitemid 44025361)
20. Yeon SB, Sabir A, Clouse M, Martinezclark PO, Peters DC, Hauser TH, Gibson CM, Nezafat R, Maintz D, Manning WJ, Botnar RM. Delayed-enhancement cardiovascular magnetic resonance coronary artery wall imaging: comparison with multislice computed tomography and quantitative coronary angiography. J Am Coll Cardiol. 2007;50:441-447. (Pubitemid 47088127)
21. Phinikaridou A, Ruberg FL, Hallock KJ, Qiao Y, Hua N, Viereck J, Hamilton JA. In vivo detection of vulnerable atherosclerotic plaque by MRI in a rabbit model. Circ Cardiovasc Imaging. 2009;3:323-332.
22. Winter PM, Morawski AM, Caruthers SD, Fuhrhop RW, Zhang H, Williams TA, Allen JS, Lacy EK, Robertson JD, Lanza GM, Wickline SA. Molecular imaging of angiogenesis in early-stage atherosclerosis with alpha(v)beta3-integrin-targeted nanoparticles. Circulation. 2003; 108:2270-2274. (Pubitemid 37363046)
23. Botnar RM, Perez AS, Witte S, Wiethoff AJ, Laredo J, Hamilton J, Quist W, Parsons EC Jr, Vaidya A, Kolodziej A, Barrett JA, Graham PB, Weisskoff RM, Manning WJ, Johnstone MT. In vivo molecular imaging of acute and subacute thrombosis using a fibrin-binding magnetic resonance imaging contrast agent. Circulation. 2004;109: 2023-2029. (Pubitemid 38544494)
24. Amirbekian V, Lipinski MJ, Briley-Saebo KC, Amirbekian S, Aguinaldo JG, Weinreb DB, Vucic E, Frias JC, Hyafil F, Mani V, Fisher EA, Fayad ZA. Detecting and assessing macrophages in vivo to evaluate atherosclerosis noninvasively using molecular MRI. Proc Natl Acad Sci USA. 2007;104:961-966. (Pubitemid 46154719)
25. Ronald JA, Chen JW, Chen Y, Hamilton AM, Rodriguez E, Reynolds F, Hegele RA, Rogers KA, Querol M, Bogdanov A, Weissleder R, Rutt BK. Enzyme-sensitive magnetic resonance imaging targeting myeloperoxidase identifies active inflammation in experimental rabbit atherosclerotic plaques. Circulation. 2009;120:592-599.
26. Makowski MR, Wiethoff AJ, Blume U, Cuello F, Warley A, Jansen CH, Nagel E, Razavi R, Onthank DC, Cesati RR, Marber MS, Schaeffter T, Smith A, Robinson SP, Botnar RM. Assessment of atherosclerotic plaque burden with an elastin-specific magnetic resonance contrast agent. Nature Med. 2011;17:383-388.
27. Nguyen PK, Meyer C, Engvall J, Yang P, McConnell MV. Noninvasive assessment of coronary vasodilation using cardiovascular magnetic resonance in patients at high risk for coronary artery disease. J Cardiovasc Magn Reson. 2008;10:28.
28. Terashima M, Nguyen PK, Rubin GD, Iribarren C, Courtney BK, Go AS, Fortmann SP, McConnell MV. Impaired coronary vasodilation by magnetic resonance angiography is associated with advanced coronary artery calcification. J Am Coll Cardiol Cardiovasc Imaging. 2008;1: 167-173. (Pubitemid 351445399)
29. Hays AG, Hirsch GA, Kelle S, Gerstenblith G, Weiss RG, Stuber M. Noninvasive visualization of coronary artery endothelial function in healthy subjects and in patients with coronary artery disease. J Am Coll Cardiol. 2010;56:1657-1665.
30. Lauffer RB, Parmelee DJ, Ouellet HS, Dolan RP, Sajiki H, Scott DM, Bernard PJ, Buchanan EM, Ong KY, Tyeklar Z, Midelfort KS, McMurry TJ, Walovitch RC. Ms-325: a small-molecule vascular imaging agent for magnetic resonance imaging. Acad Radiol. 1996;3(suppl 2):S356-S358.
31. Caravan P, Cloutier NJ, Greenfield MT, McDermid SA, Dunham SU, Bulte JW, Amedio JC Jr, Looby RJ, Supkowski RM, Horrocks WD Jr, McMurry TJ, Lauffer RB. The interaction of MS-325 with human serum albumin and its effect on proton relaxation rates. J Am Chem Soc. 2002;124:3152-3162. (Pubitemid 34249987)
32. Lobbes MB, Miserus RJ, Heeneman S, Passos VL, Mutsaers PH, Debernardi N, Misselwitz B, Post M, Daemen MJ, van Engelshoven JM, Leiner T, Kooi ME. Atherosclerosis: contrast-enhanced MR imaging of vessel wall in rabbit model-comparison of gadofosveset and gadopentetate dimeglumine. Radiology. 2009;250:682-691.
33. Lobbes MB, Heeneman S, Passos VL, Welten R, Kwee RM, van der Geest RJ, Wiethoff AJ, Caravan P, Misselwitz B, Daemen MJ, van Engelshoven JM, Leiner T, Kooi ME. Gadofosveset-enhanced magnetic resonance imaging of human carotid atherosclerotic plaques: a proof-ofconcept study. Invest Radiol. 2010;45:275-281.
34. Pedersen SF, Thrysoe SA, Paaske WP, Thim T, Falk E, Ringgaard S, Kim WY. CMR assessment of endothelial damage and angiogenesis in porcine coronary arteries using gadofosveset. J Cardiovasc Magn Reson. 2011; 13:10.
35. Constantinides P, Robinson M. Ultrastructural injury of arterial endothelium. Arch Pathol. 1969;88:99-117.
36. Eldredge H. Species dependence on plasma protein binding and relaxivity of the Gd-based MRI contrast agent MS-325. Invest Radiol. 2006;1-15.
37. Fry DL. Aortic Evans blue dye accumulation: its measurement and interpretation. Am J Physiol. 1977;232:H204-H222. (Pubitemid 8077521)
38. Bell F. Aortic endothelial permeability to albumin in young pigs. 1974;1-12.
39. Nakashima Y, Plump AS, Raines EW, Breslow JL, Ross R. ApoEdeficient mice develop lesions of all phases of atherosclerosis throughout the arterial tree. Arterioscler Thromb. 1994;14:133-140.
40. Rosenfeld ME, Polinsky P, Virmani R, Kauser K, Rubanyi G, Schwartz SM. Advanced atherosclerotic lesions in the innominate artery of the apoE knockout mouse. Arterioscler Thromb Vasc Biol. 2000;20: 2587-2592.
41. Balint A, Veress B, Jellinek H. Modifications of surface coat of aortic endothelial cells in hyperlipemic rats. Pathol Eur. 1974;9:105-108.
42. Henics T, Wheatley DN. Cytoplasmic vacuolation, adaptation and cell death: a view on new perspectives and features. Biol Cell. 1999;91: 485-498. (Pubitemid 29504720)
43. Treasure CB, Klein JL, Weintraub WS, Talley JD, Stillabower ME, Kosinski AS, Zhang J, Boccuzzi SJ, Cedarholm JC, Alexander RW. Beneficial effects of cholesterol-lowering therapy on the coronary endothelium in patients with coronary artery disease. N Engl J Med. 1995; 332:481-487.
44. Egashira K, Hirooka Y, Kai H, Sugimachi M, Suzuki S, Inou T, Takeshita A. Reduction in serum cholesterol with pravastatin improves endothelium-dependent coronary vasomotion in patients with hypercholesterolemia. Circulation. 1994;89:2519-2524.
45. Wolfrum S, Jensen KS, Liao JK. Endothelium-dependent effects of statins. Arterioscler Thromb Vasc Biol. 2003;23:729-736. (Pubitemid 36566160)
46. Cooper JA, Del Vecchio PJ, Minnear FL, Burhop KE, Selig WM, Garcia JG, Malik AB. Measurement of albumin permeability across endothelial monolayers in vitro. J Appl Physiol. 1987;62:1076-1083. (Pubitemid 17073906)
47. Schachinger V, Britten MB, Zeiher AM. Prognostic impact of coronary vasodilator dysfunction on adverse long-term outcome of coronary heart disease. Circulation. 2000;101:1899-1906. (Pubitemid 30225269)
48. Nitenberg A, Chemla D, Antony I. Epicardial coronary artery constriction to cold pressor test is predictive of cardiovascular events in hypertensive patients with angiographically normal coronary arteries and without other major coronary risk factor. Atherosclerosis. 2004;173:115-123. (Pubitemid 38224203)
49. Dupouy P, Geschwind HJ, Pelle G, Gallot D, Dubois-Rande JL. Assessment of coronary vasomotion by intracoronary ultrasound. Am Heart J. 1993;126:76-85. (Pubitemid 23201576)
50. Anderson TJ, Gerhard MD, Meredith IT, Charbonneau F, Delagrange D, Creager MA, Selwyn AP, Ganz P. Systemic nature of endothelial dysfunction in atherosclerosis. Am J Cardiol. 1995;75:71B-74B.